EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:144653 - N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(1−)
| Formula | C61H99N4O45R2 |
| Net Charge | -1 |
| Average Mass (excl. R groups) | 1608.441 |
| Monoisotopic Mass (excl. R groups) | 1607.55813 |
| SMILES | [1*][C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O[C@H]5O[C@H](CO)[C@H](O)[C@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O[C@]7(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@]([H])([C@H](O)[C@H](O)CO)O7)[C@H]6O)[C@H]5NC(C)=O)[C@H]4O[C@@H]4O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]4O)[C@H](O)[C@H]3NC(C)=O)[C@H]2O)[C@H](O)[C@H]1O)NC([2*])=O |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(1−) (CHEBI:144653) has part β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide (CHEBI:144648) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(1−) (CHEBI:144653) is a Neolacto-series glycosphingolipid (CHEBI:183225) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(1−) (CHEBI:144653) is a sialoheptaosylceramide (CHEBI:60914) |
| Incoming Relation(s) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:144655) is a N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(1−) (CHEBI:144653) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:144654) is a N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(1−) (CHEBI:144653) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:144657) is a N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(1−) (CHEBI:144653) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:144656) is a N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(1−) (CHEBI:144653) |
| Synonyms | Source |
|---|---|
| α-NeuNAc-(2→3)-β-D-Gal-(1→3)-α-D-GalNAc-(1→3)-[α-L-Fuc-(1→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer(1−) | SUBMITTER |
| blood antigen group type II sialosylgalactosyl-A | SUBMITTER |
| UniProt Name | Source |
|---|---|
| a neolactoside IV3-α-[NeuNAc-α-(2→3)-Gal-β-(1→3)-GalNAc],IV2-α-Fuc-nLc4Cer | UniProt |
| Citations |
|---|